{"cluster": 20, "subcluster": 30, "abstract_summ": "Given the inherent disadvantages of serological testing, antibody testing alone should not be used when deciding patient care and should be combined with PCR testing.Our findings suggest that patients who develop severe illness might experience longer virus exposure times and develop a more severe inflammatory response.We performed a serological study of recent blood donors in Scotland to detect antibodies to SARS-CoV-2 as a marker of past infection.Serial follow up studies are needed to track infection and seroconversion in this and other similar populations However, these data indicate that sero-surveys of blood banks can serve as a useful tool for tracking the emergence and progression of an epidemic like the current SARS-CoV-2 outbreak.In many parts of the United States, SARS-CoV-2 cases have reached peak infection rates, prompting administrators to create protocols to resume elective cases.", "title_summ": "Efficacy of Serology Testing in Predicting Reinfection in Patients with SARS-CoV-2.Neutralising antibodies to SARS coronavirus 2 in Scottish blood donors - a pilot study of the value of serology to determine population exposureCharacteristics of patients with coronavirus disease (COVID\u201019) confirmed using an IgM\u2010IgG antibody test", "title_abstract_phrases": "Characteristics of patients with coronavirus disease (COVID\u201019) confirmed using an IgM\u2010IgG antibody testCoronavirus disease (COVID\u201019), caused by a novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102), has rapidly developed into a pandemic since it was first reported in December 2019.Efficacy of Serology Testing in Predicting Reinfection in Patients with SARS-CoV-2.In many parts of the United States, SARS-CoV-2 cases have reached peak infection rates, prompting administrators to create protocols to resume elective cases.Given the inherent disadvantages of serological testing, antibody testing alone should not be used when deciding patient care and should be combined with PCR testing.We performed a serological study of recent blood donors in Scotland to detect antibodies to SARS-CoV-2 as a marker of past infection.In total, 56 patients were enrolled in this study and SARS\u2010CoV\u20102 was detected by using both IgM\u2010IgG antibody and nucleic acid tests."}